
    
      Patients fulfilling the inclusion criteria will be randomly assigned into one of 2 groups:

      Group G (Intervention group): Patients will receive Glycopyrrolate 0.2 mg IV every 8 hours.

      Group C (Control group): Patients will receive 2 mL Normal saline every 8 hours.

      Both injections will be labelled as drug A and drug B in the satellite pharmacy .

      Both the attending physician, nurse and data collector will be blinded to the injection
      given.

      Measurements data will be collected and recorded daily in the pre-prepared CRF during the
      study period.
    
  